Organization
Crown Princess Mary Cancer Centre Westmead
4 abstracts
Abstract
A randomised, controlled, multicentre trial of imiquimod versus radiotherapy for lentigo maligna.Org: Melanoma Institute Australia, The University of Sydney, Chris O'Brien Lifehouse, Icon Cancer Centre, Faculty of Medicine and Health, The University of Sydney,
Abstract
A 19-protein signature to predict outcomes in a cohort of stage II and III CRC.Org: The Westmead Institute for Medical Research, ProCan, Children’s Medical Research Institute, The University of Sydney, ProCan Oncology,
Abstract
Trastuzumab emtansine (T-DM1) in advanced cancers with HER2 mutations or amplification: Results from the Molecular Screening and Therapeutics (MoST) Program substudy.Org: NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia, Sydney, Australia, Garvan Institute of Medical Research,
Abstract
Nature and management of melanoma recurrences following adjuvant anti-PD-1 (PD1) therapy.Org: Melanoma Institute Australia, Netherlands Cancer Institute (NKI), Department of Dermatology, APHP St Louis, Alfred Health,